To validate the reduction of SAMD14 in MCs isolated from tumor regions (MC-T), we assessed SAMD14 transcript expression in an independent cohort of patient-matched prostate MCs (n = 4; Validation cohort; Table S1). This evidence concerns the gene SAMD14 and neoplasm.